S&P 500   4,283.74 (+0.23%)
DOW   33,999.04 (+0.06%)
QQQ   329.28 (+0.24%)
AAPL   174.15 (-0.23%)
MSFT   290.17 (-0.39%)
META   174.66 (-0.11%)
GOOGL   120.17 (+0.52%)
AMZN   142.30 (+0.14%)
TSLA   908.61 (-0.37%)
NVDA   187.73 (+2.39%)
NIO   19.91 (-0.85%)
BABA   90.74 (+1.08%)
AMD   100.44 (+2.21%)
T   18.43 (+0.05%)
MU   62.98 (+2.21%)
CGC   3.81 (-6.16%)
F   16.15 (+0.75%)
GE   79.21 (-0.89%)
DIS   122.67 (-0.11%)
AMC   19.29 (-9.69%)
PYPL   99.86 (+0.44%)
PFE   48.58 (-1.40%)
NFLX   245.17 (+1.67%)
S&P 500   4,283.74 (+0.23%)
DOW   33,999.04 (+0.06%)
QQQ   329.28 (+0.24%)
AAPL   174.15 (-0.23%)
MSFT   290.17 (-0.39%)
META   174.66 (-0.11%)
GOOGL   120.17 (+0.52%)
AMZN   142.30 (+0.14%)
TSLA   908.61 (-0.37%)
NVDA   187.73 (+2.39%)
NIO   19.91 (-0.85%)
BABA   90.74 (+1.08%)
AMD   100.44 (+2.21%)
T   18.43 (+0.05%)
MU   62.98 (+2.21%)
CGC   3.81 (-6.16%)
F   16.15 (+0.75%)
GE   79.21 (-0.89%)
DIS   122.67 (-0.11%)
AMC   19.29 (-9.69%)
PYPL   99.86 (+0.44%)
PFE   48.58 (-1.40%)
NFLX   245.17 (+1.67%)
S&P 500   4,283.74 (+0.23%)
DOW   33,999.04 (+0.06%)
QQQ   329.28 (+0.24%)
AAPL   174.15 (-0.23%)
MSFT   290.17 (-0.39%)
META   174.66 (-0.11%)
GOOGL   120.17 (+0.52%)
AMZN   142.30 (+0.14%)
TSLA   908.61 (-0.37%)
NVDA   187.73 (+2.39%)
NIO   19.91 (-0.85%)
BABA   90.74 (+1.08%)
AMD   100.44 (+2.21%)
T   18.43 (+0.05%)
MU   62.98 (+2.21%)
CGC   3.81 (-6.16%)
F   16.15 (+0.75%)
GE   79.21 (-0.89%)
DIS   122.67 (-0.11%)
AMC   19.29 (-9.69%)
PYPL   99.86 (+0.44%)
PFE   48.58 (-1.40%)
NFLX   245.17 (+1.67%)
S&P 500   4,283.74 (+0.23%)
DOW   33,999.04 (+0.06%)
QQQ   329.28 (+0.24%)
AAPL   174.15 (-0.23%)
MSFT   290.17 (-0.39%)
META   174.66 (-0.11%)
GOOGL   120.17 (+0.52%)
AMZN   142.30 (+0.14%)
TSLA   908.61 (-0.37%)
NVDA   187.73 (+2.39%)
NIO   19.91 (-0.85%)
BABA   90.74 (+1.08%)
AMD   100.44 (+2.21%)
T   18.43 (+0.05%)
MU   62.98 (+2.21%)
CGC   3.81 (-6.16%)
F   16.15 (+0.75%)
GE   79.21 (-0.89%)
DIS   122.67 (-0.11%)
AMC   19.29 (-9.69%)
PYPL   99.86 (+0.44%)
PFE   48.58 (-1.40%)
NFLX   245.17 (+1.67%)
NASDAQ:BNFT

Benefitfocus - BNFT Stock Forecast, Price & News

$7.77
+0.26 (+3.46%)
(As of 08/18/2022 12:00 AM ET)
Add
Compare
Today's Range
$7.27
$7.86
50-Day Range
$7.20
$9.53
52-Week Range
$7.10
$13.06
Volume
108,148 shs
Average Volume
121,334 shs
Market Capitalization
$266.02 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$10.00

Benefitfocus MarketRank™ Forecast

Analyst Rating
Hold
2.00 Rating Score
Upside/​Downside
28.7% Upside
$10.00 Price Target
Short Interest
Healthy
2.89% of Float Sold Short
Dividend Strength
N/A
Sustainability
-0.31
Upright™ Environmental Score
News Sentiment
0.63mentions of Benefitfocus in the last 14 days
Based on 6 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Decreasing
From ($0.18) to ($0.78) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.23 out of 5 stars

Computer And Technology Sector

345th out of 660 stocks

Prepackaged Software Industry

123rd out of 230 stocks

BNFT stock logo

About Benefitfocus (NASDAQ:BNFT) Stock

Benefitfocus, Inc. provides cloud-based benefits management technology solutions for employers and health plans in the United States. Its products for employers comprise Benefitplace, a cloud-based benefits management portal that streamlines online enrollment, employee communication, and benefit administration; Health Insights, a data analytics solution; ACA Management and Reporting, a solution for employers to manage ACA compliance; Billing & Payments, an application that synchronizes enrollment and billing information to streamline the monthly billing process, automate adjustments, and enhance accuracy of payments; and COBRA Administration, a solution that simplifies management of Consolidated Omnibus Budget Reconciliation Act, benefits. The company's products for health plans include Enrollment that provides platform for carriers to automate enrollment across all segments of their commercial group business; Billing & Payments, an electronic invoice presentment and payment solution; Exchange, a solution that bridges the integration gap between health plan and employer systems; and Quoting that gives health plans and brokers tools to organize and proactively manage accounts, track leads, generate quotes, and create proposals for multiple products. Its products for brokers consist of Health Insights that support strategic decisions for their clients with on-demand health plan analytics; Benefit Catalog, which allows brokers to offer products to their clients; and benefit catalog consultative support for brokers through benefit advisors. The company also provides implementation services to its customers in order to help ensure seamless deployment and effective utilization of its solutions; and employers with expanded support services. The company was incorporated in 2000 and is headquartered in Charleston, South Carolina.

Analyst Ratings Changes

A number of brokerages recently commented on BNFT. StockNews.com raised Benefitfocus from a "hold" rating to a "buy" rating in a research note on Tuesday, July 19th. William Blair reiterated a "market perform" rating on shares of Benefitfocus in a report on Thursday, August 4th. Finally, Piper Sandler downgraded shares of Benefitfocus from an "overweight" rating to a "neutral" rating and dropped their target price for the stock from $16.00 to $9.00 in a research note on Wednesday, June 22nd.

Benefitfocus Stock Up 3.3 %

Shares of NASDAQ:BNFT traded up $0.25 during midday trading on Thursday, reaching $7.76. The company's stock had a trading volume of 8,545 shares, compared to its average volume of 75,202. The firm has a market capitalization of $265.70 million, a PE ratio of -7.09 and a beta of 1.64. The stock has a fifty day moving average of $8.07 and a 200 day moving average of $9.64. Benefitfocus has a twelve month low of $7.10 and a twelve month high of $13.06.

Benefitfocus (NASDAQ:BNFT - Get Rating) last announced its earnings results on Wednesday, August 3rd. The software maker reported ($0.25) earnings per share for the quarter, missing the consensus estimate of ($0.21) by ($0.04). The firm had revenue of $56.59 million during the quarter, compared to analyst estimates of $56.37 million. During the same period last year, the firm posted ($0.31) earnings per share. Sell-side analysts anticipate that Benefitfocus will post -0.18 earnings per share for the current fiscal year.

Receive BNFT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Benefitfocus and its competitors with MarketBeat's FREE daily newsletter.

BNFT Stock News Headlines

Benefitfocus: Q2 Earnings Insights - Benzinga
Benefitfocus: Q2 Earnings Snapshot - Greenwich Time
Earnings Outlook For Benefitfocus - Benzinga
Benefitfocus (BNFT) Scheduled to Post Earnings on Wednesday
See More Headlines
Receive BNFT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Benefitfocus and its competitors with MarketBeat's FREE daily newsletter.

BNFT Company Calendar

Last Earnings
8/03/2022
Today
8/18/2022
Next Earnings (Estimated)
11/02/2022
Fiscal Year End
12/31/2022

Industry, Sector and Symbol

Industry
Prepackaged software
Sub-Industry
N/A
Current Symbol
NASDAQ:BNFT
Employees
1,100
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$10.00
High Stock Price Forecast
$11.00
Low Stock Price Forecast
$9.00
Forecasted Upside/Downside
+28.7%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
3 Analysts

Profitability

Net Income
$-32,170,000.00
Pretax Margin
-12.74%

Debt

Sales & Book Value

Annual Sales
$263.10 million
Cash Flow
$0.48 per share
Book Value
($2.91) per share

Miscellaneous

Free Float
29,149,000
Market Cap
$266.02 million
Optionable
Optionable
Beta
1.64

Key Executives

  • Mr. Matthew C. Levin (Age 49)
    Pres, CEO & Director
    Comp: $858.56k
  • Ms. Alpana WegnerMs. Alpana Wegner (Age 49)
    CFO & Treasurer
    Comp: $517.74k
  • Mr. Michael Bauer
    Investor Relations
  • Ms. Lou Anne Gilmore (Age 65)
    VP of Corp. Devel.
  • Mr. Peter Anthony Allen (Age 61)
    Sr. VP of Sales & Marketing
  • Ms. Ana Perez
    Chief Marketing Officer
  • Ms. Robin Kirby
    Chief HR Officer
  • Mr. Steve Malme
    Sr. VP of Platform Strategy & Experience
  • Mr. Scott Gibson
    Sr. VP of HR
  • Mr. Ravi Metta
    Exec. VP of Product & Engineering













BNFT Stock - Frequently Asked Questions

Should I buy or sell Benefitfocus stock right now?

3 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Benefitfocus in the last twelve months. There are currently 3 hold ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" BNFT shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in BNFT, but not buy additional shares or sell existing shares.
View BNFT analyst ratings
or view top-rated stocks.

What is Benefitfocus' stock price forecast for 2022?

3 equities research analysts have issued 12 month price targets for Benefitfocus' stock. Their BNFT share price forecasts range from $9.00 to $11.00. On average, they anticipate the company's stock price to reach $10.00 in the next year. This suggests a possible upside of 28.7% from the stock's current price.
View analysts price targets for BNFT
or view top-rated stocks among Wall Street analysts.

How have BNFT shares performed in 2022?

Benefitfocus' stock was trading at $10.66 at the beginning of the year. Since then, BNFT stock has decreased by 27.1% and is now trading at $7.77.
View the best growth stocks for 2022 here
.

When is Benefitfocus' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, November 2nd 2022.
View our BNFT earnings forecast
.

How were Benefitfocus' earnings last quarter?

Benefitfocus, Inc. (NASDAQ:BNFT) posted its earnings results on Wednesday, August, 3rd. The software maker reported ($0.25) EPS for the quarter, missing analysts' consensus estimates of ($0.21) by $0.04. The software maker earned $56.59 million during the quarter, compared to the consensus estimate of $56.37 million. During the same quarter in the previous year, the business posted ($0.31) earnings per share.

What guidance has Benefitfocus issued on next quarter's earnings?

Benefitfocus updated its third quarter 2022 earnings guidance on Wednesday, August, 10th. The company provided earnings per share (EPS) guidance of -$0.18--$0.12 for the period, compared to the consensus earnings per share estimate of -$0.08. The company issued revenue guidance of $55.00 million-$57.00 million, compared to the consensus revenue estimate of $60.52 million.

What is Matt Levin's approval rating as Benefitfocus' CEO?

34 employees have rated Benefitfocus Chief Executive Officer Matt Levin on Glassdoor.com. Matt Levin has an approval rating of 60% among the company's employees. This puts Matt Levin in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies. 53.0% of employees surveyed would recommend working at Benefitfocus to a friend.

What other stocks do shareholders of Benefitfocus own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Benefitfocus investors own include Hawkins (HWKN), CA (CA), Endologix (ELGX), BlackRock (BLK), Chipotle Mexican Grill (CMG), Micron Technology (MU), Designer Brands (DBI), STMicroelectronics (STM), Athabasca Oil (ATH) and

What is Benefitfocus' stock symbol?

Benefitfocus trades on the NASDAQ under the ticker symbol "BNFT."

Who are Benefitfocus' major shareholders?

Benefitfocus' stock is owned by many different retail and institutional investors. Top institutional investors include Needham Investment Management LLC (3.48%), Baillie Gifford & Co. (2.93%), State Street Corp (1.60%), Deutsche Bank AG (1.13%), Mirae Asset Global Investments Co. Ltd. (1.04%) and Horrell Capital Management Inc. (0.98%). Insiders that own company stock include Alpana Wegner, Annmarie Fini, Indaba Capital Management, LP, James P Restivo and Matthew Levin.
View institutional ownership trends
.

How do I buy shares of Benefitfocus?

Shares of BNFT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Benefitfocus' stock price today?

One share of BNFT stock can currently be purchased for approximately $7.77.

How much money does Benefitfocus make?

Benefitfocus (NASDAQ:BNFT) has a market capitalization of $266.02 million and generates $263.10 million in revenue each year. The software maker earns $-32,170,000.00 in net income (profit) each year or ($1.07) on an earnings per share basis.

How many employees does Benefitfocus have?

The company employs 1,100 workers across the globe.

How can I contact Benefitfocus?

Benefitfocus' mailing address is 100 BENEFITFOCUS WAY, CHARLESTON SC, 29492. The official website for the company is www.benefitfocus.com. The software maker can be reached via phone at (843) 849-7476, via email at michael.bauer@benefitfocus.com, or via fax at 843-849-9485.

This page (NASDAQ:BNFT) was last updated on 8/18/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.